Comments

Vera Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Vera Therapeutics (VERA) operate in?

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

VERANASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$19.93

1.065.62%

At close: -

$20.26

0.331.66%

After Hours: 7:30 PM EDT

Vera Therapeutics (VERA) Forecast

News Earnings Vera Therapeutics (VERA) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Vera Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:VERA | Benzinga

Explore Vera Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for VERA.

Open	$19.06
Close	$19.93
Volume / Avg.	1.79M / 1.01M
Day Range	$18.76 - $20.21
52 Wk Range	18.53 - 51.61
Market Cap	$1.29B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	12.77%
Days to Cover	4.65

Recent News

Kidney Disease-Focused Vera Therapeutics Concludes Enrollment In Pivotal Study, Targets 2026 Commercial Launch

Vera Therapeutics completes enrollment in Phase 3 atacicept trial for IgAN, with interim efficacy results expected this quarter to support 2025 FDA filing.

Vandana Singh

This Expand Energy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Avi Kapoor

Top 3 Health Care Stocks That Could Blast Off This Quarter

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Feb

Mar

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.8

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$19.06
Close	$19.93
Volume / Avg.	1.79M / 1.01M
Day Range	$18.76 - $20.21
52 Wk Range	18.53 - 51.61
Market Cap	$1.29B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	42
Short Interest	12.77%
Days to Cover	4.65

About Vera Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and com...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vera Therapeutics (VERA) stock?

You can purchase shares of Vera Therapeutics (NASDAQ:VERA) through any online brokerage.

View our list of the best stock brokerages

Who are Vera Therapeutics (VERA) competitors?

Other companies in Vera Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), 89bio (NASDAQ:ETNB), Gyre Therapeutics (NASDAQ:GYRE), Syndax Pharmaceuticals (NASDAQ:SNDX) and CareDx (NASDAQ:CDNA).

What is the forecast, or price target, for Vera Therapeutics (VERA) stock?

Vera Therapeutics has a consensus price target of $51.00.

What is the current price for Vera Therapeutics (VERA)?

The stock price for Vera Therapeutics (NASDAQ: VERA) is $20.26 last updated May 29, 2025 at 7:30 PM EDT.

Does Vera Therapeutics (VERA) pay a dividend?

A quarterly cash dividend of 0.02 per share of Class A Common Stock. The quarterly cash dividend was payable on Invalid DateTime to stockholders of record on January 10, 1996.

When is Vera Therapeutics (NASDAQ:VERA) reporting earnings?

Vera Therapeutics’s Q2 earnings are confirmed for Thursday, August 7, 2025.

Is Vera Therapeutics (VERA) going to split?

There is no upcoming split for Vera Therapeutics.

What sector and industry does Vera Therapeutics (VERA) operate in?

Vera Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.